ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

XBI SPDR S&P Biotech

90.26
1.92 (2.17%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 11,012,031
Bid Price
Ask Price
News -
Day High 91.70

Low
63.80

52 Week Range

High
103.52

Day Low 89.78
Company Name Etf Ticker Symbol Market Type
SPDR S&P Biotech XBI AMEX Exchange Traded Fund
  Price Change Change Percent Etf Price Last Traded
1.92 2.17% 90.26 19:42:45
Open Price Low Price High Price Close Price Prev Close
90.98 89.78 91.70 89.98 88.34
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
122,654 11,012,031  90.39  995,415,330 - 63.80 - 103.52
Last Trade Time Type Quantity Etf Price Currency
20:00:00 230,667  89.98 USD

SPDR S&P Biotech (XBI) Options Flow Summary

Overall Flow

Bearish

Net Premium

-3M

Calls / Puts

75.93%

Buys / Sells

119.75%

OTM / ITM

120.93%

Sweeps Ratio

0.06%

SPDR S&P Biotech Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.97B 77.43M - 18.32M 733.48M 9.47 9.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News SPDR S&P Biotech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No XBI Message Board. Create One! See More Posts on XBI Message Board See More Message Board Posts

XBI Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week82.5891.7081.6386.0810,914,2817.689.30%
1 Month88.9691.76581.1486.3311,142,2681.301.46%
3 Months89.96103.5281.1492.4211,318,1960.300.33%
6 Months69.46103.5264.9987.0911,370,74720.8029.95%
1 Year81.08103.5263.8083.559,468,4559.1811.32%
3 Years137.93141.5061.7889.019,633,231-47.67-34.56%
5 Years84.68174.7961.7893.587,998,0805.586.59%

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Your Recent History

Delayed Upgrade Clock